Diagnosoft is a healthcare software analysis startup established in 2002 in the United States. The company is renowned for developing HARP®, the first FDA 510k-cleared software for tagged MR images, which forms part of its comprehensive solution for the analysis and quantification of cardiac magnetic resonance images.
Moreover, Diagnosoft is committed to developing transformative clinical analytics solutions for the healthcare sector. Its FUSION product utilizes a unique clinical insight and intelligence engine to aggregate patient data and generate real-time, comprehensive views of patient health status. This cutting-edge software compiles and analyzes data directly from EMRs and other sources, providing healthcare providers with an easily interpreted and meaningful view of the patient’s status at the point of care.
The company’s most recent funding round was a $4.00M Series B investment led by Ideavelopers on 29 January 2009.